Former Little Mix singer Jesy Nelson has marked a significant victory in her campaign for universal newborn screening, as the NHS announces an accelerated rollout for spinal muscular atrophy (SMA) tests. Health Secretary Wes Streeting confirmed that screenings will now begin in October 2026, three months ahead of the original schedule, as part of in-screening evaluations (ISE).
Nelson's Personal Drive for Change
Nelson's advocacy stems from a deeply personal experience: her twins were diagnosed with SMA, a rare degenerative condition that leads to progressive muscle wastage. She has been vocal about the critical importance of early detection, sharing that while her children received treatment, they cannot regain muscle function already lost. This campaign has highlighted the life-changing impact that timely screening can have on affected families.
Health Secretary's Announcement and Broader Goals
In an update, Wes Streeting emphasised the government's commitment to improving newborn health outcomes. The earlier start date for SMA screenings reflects a responsive approach to public advocacy and medical urgency. Giles Lomax, chief executive of SMA UK, welcomed the news, stating that the organisation's goal is to extend the screening programme across all of England and the home nations, ensuring broader access and equity in healthcare.
The initiative at Great Ormond Street Hospital, where Nelson's twins are being treated, serves as a beacon for the potential benefits of early intervention. Experts note that SMA, if caught early, can be managed more effectively, potentially slowing disease progression and improving quality of life. Nelson expressed pride in the milestone, calling it a step forward in safeguarding future generations from the ravages of this condition.
This development underscores the power of celebrity influence in shaping health policy, as Nelson's platform has amplified a crucial public health issue. It also aligns with ongoing efforts in the NHS to enhance preventive care and address rare diseases through systematic screening protocols.
